/주식/SOPH
SOPH

SOPH

USD

SOPHiA GENETICS SA Ordinary Shares

$4.680-0.140 (-2.905%)

실시간 가격

Healthcare
Health Information Services
스위스

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$4.820

고가

$5.110

저가

$4.630

거래량

0.18M

기업 기본 정보

시가총액

316.3M

산업

Health Information Services

국가

Switzerland

거래 통계

평균 거래량

0.09M

거래소

NMS

통화

USD

52주 범위

저가 $2.58현재가 $4.680고가 $5.3

관련 뉴스

Analyst Upgrades

BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7

BTIG analyst Mark Massaro maintains Sophia Genetics with a Buy and raises the price target from $6 to $7.

더 보기
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7
PR Newswire

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended...

더 보기
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
GlobeNewswire

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management expectations.Third quarter

더 보기
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
PR Newswire

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third...

더 보기
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025